Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Outlook Therapeutics, Inc. (OTLK) on Behalf of InvestorsBusiness Wire • 11/07/23
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Outlook Therapeutics, Inc. (OTLK) on Behalf of InvestorsBusiness Wire • 11/07/23
OUTLOOK ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Outlook Therapeutics, Inc. and Encourages Investors to Contact the FirmBusiness Wire • 11/07/23
The Law Offices of Frank R. Cruz Announces Investigation of Outlook Therapeutics, Inc. (OTLK) on Behalf of InvestorsBusiness Wire • 11/07/23
OTLK INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Outlook Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitBusiness Wire • 11/06/23
OTLK SHAREHOLDER ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OTLKBusiness Wire • 11/06/23
Pomerantz Law Firm Announces the Filing of a Class Action Against Outlook Therapeutics, Inc. and Certain Officers - OTLKPRNewsWire • 11/04/23
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Outlook Therapeutics, Inc. - OTLKPRNewsWire • 11/03/23
Outlook Therapeutics® to Present at Guggenheim's 5th Annual Inflammation, Neurology & Immunology (INI) ConferenceGlobeNewsWire • 11/01/23
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Outlook Therapeutics, Inc. Corporation and Encourages Investors with Losses to Contact the FirmAccesswire • 09/27/23
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Outlook Therapeutics, Inc. Corporation and Encourages Investors with Losses to Contact the FirmAccesswire • 09/25/23
Outlook Therapeutics® to Present at the 2023 Cantor Fitzgerald Global Healthcare ConferenceGlobeNewsWire • 09/21/23
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Outlook Therapeutics, Inc. Corporation and Encourages Investors with Losses to Contact the FirmAccesswire • 09/18/23
SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against Outlook Therapeutics, Inc. Corporation and Encourages Investors with Losses to Contact the FirmAccesswire • 09/14/23
INVESTIGATION ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Outlook Therapeutics, Inc. Corporation and Encourages Investors with Losses to Contact the FirmAccesswire • 09/13/23
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Outlook Therapeutics, Inc. Corporation and Encourages Investors with Losses In Excess of $500,000 to Contact the FirmAccesswire • 09/08/23
Outlook Therapeutics® to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceGlobeNewsWire • 09/05/23
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Outlook Therapeutics, Inc. Corporation and Encourages Investors with Losses In Excess of $500,000 to Contact the FirmAccesswire • 09/02/23
Outlook Therapeutics, Inc. (OTLK) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the FirmPRNewsWire • 08/31/23
